Renal primitive neuroectodermal tumor: does age at diagnosis impact outcomes?
Mahdi Aghili1, Elham Rafiei, Mohamad Mojahed
1Cancer Institute, Tehran University of Medical Sciences.
Rare Tumors
|April 26, 2012
Summary
Primitive neuroectodermal tumor (PNET) of the kidney is a rare, malignant neoplasm. This review analyzes clinicopathological factors and prognosis in adult and pediatric renal PNET cases.
Area of Science:
- Oncology
- Pathology
Background:
- Primitive neuroectodermal tumors (PNETs) are rare, highly malignant neoplasms.
- Renal PNETs can occur across a wide age range, with a median age of 27 years.
Observation:
- A Medline search identified 79 renal PNET cases reported up to December 2010.
- The study includes a new case report and a literature review of published data.
Findings:
- Analysis focuses on clinicopathological prognostic factors for renal PNET.
- Prognosis is evaluated separately for pediatric-adolescent (≤18 years) and adult (>18 years) groups.
Implications:
- Understanding prognostic factors is crucial for managing renal PNET.
- Differentiating outcomes between age groups may inform treatment strategies.